I agree that this site is using cookies. You can find further informations here.
X
Cerveró-García, Pilar
85  results:
Search for persons X
?
1

EGFR amplification and EGFRvIII predict and participate in ..:

Álvarez-Vázquez, Andrea ; San-Segundo, Laura ; Cerveró-García, Pilar...
Neuro-Oncology.  26 (2024)  7 - p. 1230-1246 , 2024
Link: https://doi.org/10.1093/..
 
?
2

THE SRC-INHIBITORY PEPTIDE TAT-CX43266-283 TARGETS TUMOR-IN..:

Álvarez-Vázquez, Andrea ; Volovetz, Josephine ; San-Segundo, Laura...
IBRO Neuroscience Reports.  15 (2023)  - p. S166 , 2023
Link: https://doi.org/10.1016/..
 
?
3

BBB PENETRANCE, PLASMA STABILITY AND TOXICITY OF THE ANTI-T..:

Flores-Hernández, Raquel ; Álvarez-Vázquez, Andrea ; Talaverón, Rocío...
IBRO Neuroscience Reports.  15 (2023)  - p. S562 , 2023
Link: https://doi.org/10.1016/..
 
?
4

STEM-22. EFFECT OF A SRC INHIBITORY PEPTIDE BASED ON CONNEX..:

Álvarez-Vázquez, Andrea ; San-Segundo, Laura ; Cerveró-García, Pilar...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii36-vii36 , 2022
Link: https://doi.org/10.1093/..
 
?
5

BBB PENETRANCE, PLASMA STABILITY AND TOXICITY OF THE ANTI-T..:

Raquel Flores-Hernández ; Andrea Álvarez-Vázquez ; Rocío Talaverón...
http://www.sciencedirect.com/science/article/pii/S2667242123011739.  , 2023
Link: https://doi.org/10.1016/..
 
?
6

THE SRC-INHIBITORY PEPTIDE TAT-CX43266-283 TARGETS TUMOR-IN..:

Andrea Álvarez-Vázquez ; Josephine Volovetz ; Laura San-Segundo...
http://www.sciencedirect.com/science/article/pii/S2667242123002993.  , 2023
Link: https://doi.org/10.1016/..
 
?
7

VII Jornadas de Investigadoras de Castilla y León. La avent..:

Santos Sánchez, María Jesús ; Lagüela López, Susana ; Lombana González, Lorena...
8/1ACT/20.  , 2021
Link: http://hdl.handle.net/10..
 
?
8

Changes in sleep-disordered breathing from the acute to the..:

García-Ortega, Alberto ; Oscullo, Grace ; Mañas-Baena, Eva...
Sleep Medicine.  112 (2023)  - p. 88-95 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine v..:

Pulido, Federico ; Ribera, Esteban ; Lagarde, María...
Clinical Infectious Diseases.  65 (2017)  12 - p. 2112-2118 , 2017
Link: https://doi.org/10.1093/..
 
?
10

Toxicity of Asciminib in Real Clinical Practice: Analysis o..:

Lucía Pérez-Lamas ; Alejandro Luna ; Concepción Boque...
Cancer Drug Development.  , 2023
Link: https://doi.org/10.3390/..
 
?
11

Clinical outcomes after CPX‐351 in patients with high‐risk ..:

Teresa Bernal ; Ainhoa Fernández Moreno ; Almudena de LaIglesia...
https://doi.org/10.1002/cam4.6120.  , 2023
Link: https://doi.org/10.1002/..
 
?
12

Toxicity of Asciminib in Real Clinical Practice: Analysis o..:

Lucía Pérez-Lamas ; Alejandro Luna ; Concepción Boque...
https://www.mdpi.com/2072-6694/15/4/1045.  , 2023
Link: https://doi.org/10.3390/..
 
?
13

Toxicity of Asciminib in Real Clinical Practice: Analysis o..:

Pérez Lamas, Lucía ; Luna, Alejandro ; Boque, Concepción...
Reproducció del document publicat a: https://doi.org/10.3390/cancers15041045.  , 2023
Link: http://hdl.handle.net/24..
 
?
14

Toxicity of Asciminib in Real Clinical Practice : Analysis ..:

Pérez-Lamas, Lucía ; Luna, Alejandro ; Boque, Concepcion...
Cancers.  , 2023
Link: https://ddd.uab.cat/reco..
 
?
15

Aula virtual multimedia:

González Sánchez, José Luis ; Gazo Cervero, Alfonso ; Gordo Rivera, José Luis...
http://hdl.handle.net/11162/30158.  , 2000
Link: http://hdl.handle.net/11..
 
1-15